Angel M R Schols1, Floris H B M Schreuder, Elisabeth P M van Raak, Tobien H C M L Schreuder, Fergus A Rooyer, Robert J van Oostenbrugge, Julie Staals. 1. From the Department of Neurology (A.M.R.S., F.H.B.M.S., E.P.M.v.R., R.J.v.O., J.S.) and Cardiovascular Research Institute Maastricht (F.H.B.M.S., R.J.v.O., J.S.), Maastricht University Medical Center, Maastricht, The Netherlands; Department of Neurology, Atrium Medical Center, Heerlen, The Netherlands (T.H.C.M.L.S.); and Department of Neurology, Orbis Medical Center, Sittard, The Netherlands (F.A.R.).
Abstract
BACKGROUND AND PURPOSE: The aim of this study was to estimate the annual adult incidence and risk of intracerebral hemorrhage (ICH) and oral anticoagulant-associated ICH (OAC-ICH) in the Netherlands. METHODS: We retrospectively selected all consecutive adult patients with a nontraumatic ICH seen in 1 of 3 hospitals in the region South-Limburg, the Netherlands, from 2007 to 2009. Crude incidences were age-adjusted to Dutch and European population. RESULTS: We identified 652 ICH cases, of which 168 (25.8%) were OAC associated. The adult Dutch age-adjusted annual incidence of ICH and OAC-ICH was 34.8 (95% confidence interval, 32.0-37.8) and 8.7 (95% confidence interval, 7.3-10.3) per 100 000 person-years, respectively. The absolute risk of OAC-ICH was estimated at 0.46% per patient-year of OAC treatment. CONCLUSIONS: The annual incidences of ICH and OAC-ICH are relatively high in the Netherlands when compared with international literature.
BACKGROUND AND PURPOSE: The aim of this study was to estimate the annual adult incidence and risk of intracerebral hemorrhage (ICH) and oral anticoagulant-associated ICH (OAC-ICH) in the Netherlands. METHODS: We retrospectively selected all consecutive adult patients with a nontraumatic ICH seen in 1 of 3 hospitals in the region South-Limburg, the Netherlands, from 2007 to 2009. Crude incidences were age-adjusted to Dutch and European population. RESULTS: We identified 652 ICH cases, of which 168 (25.8%) were OAC associated. The adult Dutch age-adjusted annual incidence of ICH and OAC-ICH was 34.8 (95% confidence interval, 32.0-37.8) and 8.7 (95% confidence interval, 7.3-10.3) per 100 000 person-years, respectively. The absolute risk of OAC-ICH was estimated at 0.46% per patient-year of OAC treatment. CONCLUSIONS: The annual incidences of ICH and OAC-ICH are relatively high in the Netherlands when compared with international literature.
Authors: Andreas Charidimou; Andrea Morotti; Raffaella Valenti; Anne-Katrin Giese; Gregoire Boulouis; Marco Pasi; Duangnapa Roongpiboonsopit; Arne Lauer; Li Xiong; Thijs Wijnzen Van Harten; Hasan Karadeli; Panagiotis Fotiadis; Michael James Jessel; Anand Viswanathan Journal: Neurology Date: 2016-05-17 Impact factor: 9.910
Authors: Bianca T A de Greef; Floris H B M Schreuder; Mariëlle C G Vlooswijk; A H C M L Schreuder; Fergus A Rooyer; Robert J van Oostenbrugge; Rob P W Rouhl Journal: J Neurol Date: 2014-12-05 Impact factor: 4.849
Authors: Adrian R Parry-Jones; Mario Di Napoli; Joshua N Goldstein; Floris H B M Schreuder; Sami Tetri; Turgut Tatlisumak; Bernard Yan; Koen M van Nieuwenhuizen; Nelly Dequatre-Ponchelle; Matthew Lee-Archer; Solveig Horstmann; Duncan Wilson; Fulvio Pomero; Luca Masotti; Christine Lerpiniere; Daniel Agustin Godoy; Abigail S Cohen; Rik Houben; Rustam Al-Shahi Salman; Paolo Pennati; Luigi Fenoglio; David Werring; Roland Veltkamp; Edith Wood; Helen M Dewey; Charlotte Cordonnier; Catharina J M Klijn; Fabrizio Meligeni; Stephen M Davis; Juha Huhtakangas; Julie Staals; Jonathan Rosand; Atte Meretoja Journal: Ann Neurol Date: 2015-05-14 Impact factor: 10.422
Authors: M O Fakiri; M Uyttenboogaart; R Houben; R J van Oostenbrugge; J Staals; G J Luijckx Journal: Eur J Neurol Date: 2020-06-16 Impact factor: 6.089
Authors: Koen M van Nieuwenhuizen; H Bart van der Worp; Ale Algra; L Jaap Kappelle; Gabriel J E Rinkel; Isabelle C van Gelder; Roger E G Schutgens; Catharina J M Klijn Journal: Trials Date: 2015-09-04 Impact factor: 2.279
Authors: Rik Houben; Floris H B M Schreuder; Kim J Bekelaar; Danny Claessens; Robert J van Oostenbrugge; Julie Staals Journal: Front Neurol Date: 2018-02-28 Impact factor: 4.003